275 related articles for article (PubMed ID: 24607211)
1. Polyoxylglycerides and glycerides: effects of manufacturing parameters on API stability, excipient functionality and processing.
Jannin V; Rodier JD; Musakhanian J
Int J Pharm; 2014 May; 466(1-2):109-21. PubMed ID: 24607211
[TBL] [Abstract][Full Text] [Related]
2. Solid lipid excipients - matrix agents for sustained drug delivery.
Rosiaux Y; Jannin V; Hughes S; Marchaud D
J Control Release; 2014 Aug; 188():18-30. PubMed ID: 24929038
[TBL] [Abstract][Full Text] [Related]
3. From Quantum Chemistry to Prediction of Drug Solubility in Glycerides.
Alsenz J; Kuentz M
Mol Pharm; 2019 Nov; 16(11):4661-4669. PubMed ID: 31518142
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of hydroperoxides in common pharmaceutical excipients.
Wasylaschuk WR; Harmon PA; Wagner G; Harman AB; Templeton AC; Xu H; Reed RA
J Pharm Sci; 2007 Jan; 96(1):106-16. PubMed ID: 16917844
[TBL] [Abstract][Full Text] [Related]
5. Excipient variability and its impact on dosage form functionality.
Dave VS; Saoji SD; Raut NA; Haware RV
J Pharm Sci; 2015 Mar; 104(3):906-15. PubMed ID: 25561249
[TBL] [Abstract][Full Text] [Related]
6. Hydration of an amphiphilic excipient, Gelucire 44/14.
Svensson A; Neves C; Cabane B
Int J Pharm; 2004 Aug; 281(1-2):107-18. PubMed ID: 15288348
[TBL] [Abstract][Full Text] [Related]
7. Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin.
Shen H; Zhong M
J Pharm Pharmacol; 2006 Sep; 58(9):1183-91. PubMed ID: 16945176
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of the esterification of active pharmaceutical ingredients containing carboxylic acid functionality in polyethylene glycol: formulation implications.
Schou-Pedersen AM; Hansen SH; Moesgaard B; Østergaard J
J Pharm Sci; 2014 Aug; 103(8):2424-33. PubMed ID: 24961667
[TBL] [Abstract][Full Text] [Related]
9. Influence of excipients on solubility and dissolution of pharmaceuticals.
Paus R; Prudic A; Ji Y
Int J Pharm; 2015 May; 485(1-2):277-87. PubMed ID: 25749073
[TBL] [Abstract][Full Text] [Related]
10. Recent trends in stabilising peptides and proteins in pharmaceutical formulation - considerations in the choice of excipients.
Jorgensen L; Hostrup S; Moeller EH; Grohganz H
Expert Opin Drug Deliv; 2009 Nov; 6(11):1219-30. PubMed ID: 19678792
[TBL] [Abstract][Full Text] [Related]
11. Novel approach for overcoming the stability challenges of lipid-based excipients. Part 1: Screening of solid-state and physical properties of polyglycerol esters of fatty acids as advanced pharmaceutical excipients.
Corzo C; Lopes DG; Lochmann D; Reyer S; Stehr M; Salar-Behzadi S
Eur J Pharm Biopharm; 2020 Mar; 148():134-147. PubMed ID: 31982573
[TBL] [Abstract][Full Text] [Related]
12. Toward simplified oral lipid-based drug delivery using mono-/di-glycerides as single component excipients.
Ilie AR; Griffin BT; Vertzoni M; Kuentz M; Cuyckens F; Wuyts K; Kolakovic R; Holm R
Drug Dev Ind Pharm; 2020 Dec; 46(12):2051-2060. PubMed ID: 33124918
[TBL] [Abstract][Full Text] [Related]
13. Gelucire 44/14 based immediate release formulations for poorly water-soluble drugs.
da Fonseca Antunes AB; De Geest BG; Vervaet C; Remon JP
Drug Dev Ind Pharm; 2013 May; 39(5):791-8. PubMed ID: 22871141
[TBL] [Abstract][Full Text] [Related]
14. Effect of drug solubility and different excipients on floating behaviour and release from glyceryl monooleate matrices.
Kumar M K; Shah MH; Ketkar A; Mahadik KR; Paradkar A
Int J Pharm; 2004 Mar; 272(1-2):151-60. PubMed ID: 15019078
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of microwave oven heating for prediction of drug-excipient compatibilities and accelerated stability studies.
Schou-Pedersen AM; Østergaard J; Cornett C; Hansen SH
Int J Pharm; 2015 May; 485(1-2):97-107. PubMed ID: 25746946
[TBL] [Abstract][Full Text] [Related]
16. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
Prabhu S; Ortega M; Ma C
Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087
[TBL] [Abstract][Full Text] [Related]
17. Excipient Stability in Oral Solid Dosage Forms: A Review.
Darji MA; Lalge RM; Marathe SP; Mulay TD; Fatima T; Alshammari A; Lee HK; Repka MA; Narasimha Murthy S
AAPS PharmSciTech; 2018 Jan; 19(1):12-26. PubMed ID: 28895106
[TBL] [Abstract][Full Text] [Related]
18. Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective.
Chen ML
Adv Drug Deliv Rev; 2008 Mar; 60(6):768-77. PubMed ID: 18077051
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances in Co-processed APIs and Proposals for Enabling Commercialization of These Transformative Technologies.
Schenck L; Erdemir D; Saunders Gorka L; Merritt JM; Marziano I; Ho R; Lee M; Bullard J; Boukerche M; Ferguson S; Florence AJ; Khan SA; Sun CC
Mol Pharm; 2020 Jul; 17(7):2232-2244. PubMed ID: 32392068
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the versatile character of a nanoemulsion formulation.
Gué E; Since M; Ropars S; Herbinet R; Le Pluart L; Malzert-Fréon A
Int J Pharm; 2016 Feb; 498(1-2):49-65. PubMed ID: 26685727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
